Medifast, Inc. Announces First Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/30/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
Medifast (MED) Tops Q1 EPS by 3c, Offers Guidance
May 2, 2022 4:21 PM EDTMedifast (NYSE: MED) reported Q1 EPS of $3.59, $0.03 better than the analyst estimate of $3.56. Revenue for the quarter came in at $417.6 million versus the consensus estimate of $402.42 million.
GUIDANCE:
Medifast sees FY2022 EPS of $14.60-$16.05, versus the consensus of $15.62. Medifast sees... More
